Overall mortality | |||||||
---|---|---|---|---|---|---|---|
Stage | Number of studies | Total patients | Patients/events HDR | Patients/events LDR | OR | CI95% | P value |
I | 2 | 134 | 19/67 | 13/67 | 0.68 | 0.36–1.29 | 0.23 |
II | 4 | 500 | 75/257 | 62/243 | 0.84 | 0.56–1.24 | 0.38 |
III | 5 | 1079 | 238/572 | 228/507 | 1.22 | 0.95–1.56 | 0.11 |
Local recurrence | |||||||
Stage | Number of studies | Total patients | Patients/events HDR | Patients/events LDR | OR | CI95% | P value |
I | 2 | 134 | 7/67 | 3/67 | 2.31 | 0.61–8.71 | 0.22 |
II | 4 | 500 | 45/257 | 34/243 | 1.17 | 0.74–1.85 | 0.51 |
III | 5 | 1079 | 143/572 | 138/507 | 0.94 | 0.70–1.27 | 0.70 |
Grade 3 or 4 rectal complication | |||||||
Number of studies | Total patients | Patients/events HDR | Patients/events LDR | OR | CI95% | P value | |
5 | 2065 | 27/1068 | 27/997 | 0.9 | 0.52–1.56 | 0.7 | |
Grade 3 or 4 bladder complication | |||||||
Number of studies | Total patients | Patients/events HDR | Patients/events LDR | OR | CI95% | P value | |
5 | 2065 | 17/1068 | 16/997 | 0.98 | 0.49–1.96 | 0.95 | |
Grade 3 or 4 small intestine complication | |||||||
Number of studies | Total patients | Patients/events HDR | Patients/events LDR | OR | CI95% | P value | |
3 | 783 | 13/432 | 3/351 | 3.15 | 0.9–10.37 | 0.06 |